Nifty
Sensex
:
:
17327.35
58098.92
-302.45 (-1.72%)
-1020.80 (-1.73%)

Pharmaceuticals & Drugs - Global

Rating :
55/99

BSE: 500420 | NSE: TORNTPHARM

1516.20
23-Sep-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 1532.00
  • 1539.70
  • 1510.15
  • 1537.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  146018
  •  2226.27
  •  1649.25
  •  1242.08

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 51,284.64
  • 63.99
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 54,899.33
  • 1.58%
  • 8.02

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 0.46%
  • 7.10%
  • FII
  • DII
  • Others
  • 10.8%
  • 9.96%
  • 0.43%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.23
  • 7.42
  • 2.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.39
  • 12.50
  • 2.30

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.03
  • 2.76
  • -8.80

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.95
  • 40.51
  • 41.04

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.84
  • 6.91
  • 7.78

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.54
  • 18.75
  • 19.90

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
2,347.00
2,134.00
9.98%
2,131.00
1,937.00
10.02%
2,108.00
1,995.00
5.66%
2,137.00
2,017.00
5.95%
Expenses
1,635.00
1,457.00
12.22%
1,570.00
1,355.00
15.87%
1,570.00
1,388.00
13.11%
1,477.00
1,382.00
6.87%
EBITDA
712.00
677.00
5.17%
561.00
582.00
-3.61%
538.00
607.00
-11.37%
660.00
635.00
3.94%
EBIDTM
30.34%
31.72%
26.33%
30.05%
25.52%
30.43%
30.88%
31.48%
Other Income
30.00
40.00
-25.00%
56.00
39.00
43.59%
48.00
8.00
500.00%
51.00
6.00
750.00%
Interest
55.00
68.00
-19.12%
57.00
73.00
-21.92%
62.00
91.00
-31.87%
71.00
92.00
-22.83%
Depreciation
155.00
165.00
-6.06%
162.00
165.00
-1.82%
167.00
167.00
0.00%
168.00
165.00
1.82%
PBT
532.00
484.00
9.92%
-87.00
383.00
-
357.00
357.00
0.00%
472.00
384.00
22.92%
Tax
178.00
154.00
15.58%
31.00
59.00
-47.46%
108.00
60.00
80.00%
156.00
74.00
110.81%
PAT
354.00
330.00
7.27%
-118.00
324.00
-
249.00
297.00
-16.16%
316.00
310.00
1.94%
PATM
15.08%
15.46%
-5.54%
16.73%
11.81%
14.89%
14.79%
15.37%
EPS
10.46
9.75
7.28%
-3.49
9.57
-
7.36
8.77
-16.08%
9.34
9.16
1.97%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
8,723.00
8,508.04
8,004.57
7,939.31
7,672.80
5,949.83
5,815.69
6,666.85
4,653.45
4,184.72
3,211.14
Net Sales Growth
7.92%
6.29%
0.82%
3.47%
28.96%
2.31%
-12.77%
43.27%
11.20%
30.32%
 
Cost Of Goods Sold
2,515.00
2,230.75
1,960.12
1,981.79
2,041.26
1,535.17
1,629.66
1,432.13
1,280.96
1,107.58
807.98
Gross Profit
6,208.00
6,277.29
6,044.45
5,957.52
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
3,077.14
2,403.16
GP Margin
71.17%
73.78%
75.51%
75.04%
73.40%
74.20%
71.98%
78.52%
72.47%
73.53%
74.84%
Total Expenditure
6,252.00
6,076.77
5,524.49
5,768.95
5,696.31
4,600.58
4,438.42
3,937.05
3,633.29
3,233.24
2,518.92
Power & Fuel Cost
-
144.19
122.94
128.19
132.46
118.77
107.98
92.59
97.41
71.88
62.80
% Of Sales
-
1.69%
1.54%
1.61%
1.73%
2.00%
1.86%
1.39%
2.09%
1.72%
1.96%
Employee Cost
-
1,526.45
1,439.62
1,429.04
1,403.79
1,135.25
993.41
842.35
841.81
741.10
623.29
% Of Sales
-
17.94%
17.98%
18.00%
18.30%
19.08%
17.08%
12.63%
18.09%
17.71%
19.41%
Manufacturing Exp.
-
591.13
550.92
544.11
558.84
457.58
502.16
353.45
345.98
320.78
278.15
% Of Sales
-
6.95%
6.88%
6.85%
7.28%
7.69%
8.63%
5.30%
7.43%
7.67%
8.66%
General & Admin Exp.
-
637.65
633.48
801.98
763.90
677.71
578.05
637.92
463.28
398.98
324.55
% Of Sales
-
7.49%
7.91%
10.10%
9.96%
11.39%
9.94%
9.57%
9.96%
9.53%
10.11%
Selling & Distn. Exp.
-
884.91
742.63
807.39
738.03
641.30
567.70
547.05
574.40
461.53
393.07
% Of Sales
-
10.40%
9.28%
10.17%
9.62%
10.78%
9.76%
8.21%
12.34%
11.03%
12.24%
Miscellaneous Exp.
-
61.69
74.78
76.45
58.03
34.80
59.46
31.56
29.45
131.39
393.07
% Of Sales
-
0.73%
0.93%
0.96%
0.76%
0.58%
1.02%
0.47%
0.63%
3.14%
0.91%
EBITDA
2,471.00
2,431.27
2,480.08
2,170.36
1,976.49
1,349.25
1,377.27
2,729.80
1,020.16
951.48
692.22
EBITDA Margin
28.33%
28.58%
30.98%
27.34%
25.76%
22.68%
23.68%
40.95%
21.92%
22.74%
21.56%
Other Income
185.00
196.56
56.91
121.30
63.62
298.84
223.30
228.80
285.55
38.13
43.36
Interest
245.00
255.06
352.94
450.71
503.75
308.48
205.56
183.98
175.16
58.63
33.80
Depreciation
652.00
662.16
657.79
654.38
617.69
408.60
306.92
237.55
190.74
87.00
82.69
PBT
1,274.00
1,710.61
1,526.26
1,186.57
918.67
931.01
1,088.09
2,537.07
939.81
843.98
619.09
Tax
473.00
448.73
274.38
161.85
125.35
252.87
154.51
610.17
188.84
180.07
146.69
Tax Rate
37.13%
36.60%
17.98%
13.64%
22.32%
27.16%
14.20%
26.04%
20.09%
21.34%
25.22%
PAT
801.00
777.18
1,251.88
1,024.72
436.28
678.11
933.55
1,733.24
750.94
663.88
432.76
PAT before Minority Interest
801.00
777.18
1,251.88
1,024.72
436.31
678.14
933.58
1,733.27
750.97
663.91
434.91
Minority Interest
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-0.03
-2.15
PAT Margin
9.18%
9.13%
15.64%
12.91%
5.69%
11.40%
16.05%
26.00%
16.14%
15.86%
13.48%
PAT Growth
-36.48%
-37.92%
22.17%
134.88%
-35.66%
-27.36%
-46.14%
130.81%
13.11%
53.41%
 
EPS
47.34
45.93
73.99
60.56
25.78
40.08
55.17
102.44
44.38
39.24
25.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
5,952.95
5,837.17
4,823.22
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
1,421.93
Share Capital
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
42.31
Total Reserves
5,868.33
5,752.55
4,738.60
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
1,379.62
Non-Current Liabilities
2,238.15
2,924.20
3,299.15
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
926.76
619.81
Secured Loans
2,123.22
2,941.07
3,302.29
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
730.72
403.19
Unsecured Loans
0.00
0.00
1.56
3.11
6.15
11.26
10.62
13.62
13.74
51.35
Long Term Provisions
368.74
369.62
338.34
288.52
286.66
263.04
246.36
207.49
190.43
129.51
Current Liabilities
4,415.09
4,891.62
5,454.16
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
1,710.65
Trade Payables
1,674.44
2,066.81
2,048.81
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
1,067.74
Other Current Liabilities
1,365.10
1,635.36
1,860.80
1,641.26
1,151.68
687.14
822.28
446.15
371.63
275.83
Short Term Borrowings
923.04
704.40
1,090.85
934.11
1,625.60
0.00
3.32
319.07
210.43
124.62
Short Term Provisions
452.51
485.05
453.70
493.21
376.65
301.80
199.66
230.81
163.39
242.46
Total Liabilities
12,606.19
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
Net Block
6,422.65
7,064.63
7,533.12
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
875.34
819.82
Gross Block
10,728.19
10,511.53
10,334.13
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
1,278.15
Accumulated Depreciation
4,031.06
3,446.90
2,801.01
2,187.72
1,594.80
1,221.36
934.45
710.27
544.70
458.33
Non Current Assets
7,311.54
8,129.77
8,595.61
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
1,191.87
Capital Work in Progress
629.82
889.38
711.93
617.12
646.94
519.49
1,041.58
678.33
534.11
285.28
Non Current Investment
42.33
42.09
2.09
2.09
0.09
0.09
0.09
0.06
0.03
0.03
Long Term Loans & Adv.
166.55
96.84
222.19
150.58
130.96
182.32
99.66
206.92
129.47
62.84
Other Non Current Assets
50.19
36.83
126.28
196.03
72.22
122.40
85.25
50.28
60.74
23.90
Current Assets
5,294.65
5,523.22
4,980.92
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
2,560.89
Current Investments
183.98
139.05
0.02
351.35
492.27
803.55
779.59
297.59
185.63
60.44
Inventories
2,462.32
2,681.20
2,148.22
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
923.86
Sundry Debtors
1,632.48
1,523.37
1,649.34
1,435.71
1,253.45
950.89
1,445.09
1,587.26
1,099.42
687.82
Cash & Bank
403.41
603.50
666.65
816.04
867.23
893.72
647.03
567.36
769.42
626.97
Other Current Assets
612.46
512.69
443.21
405.83
683.16
672.16
459.34
532.03
343.95
261.80
Short Term Loans & Adv.
67.13
63.41
73.48
93.46
95.39
82.62
90.18
109.09
84.95
75.95
Net Current Assets
879.56
631.60
-473.24
-127.78
60.24
2,141.21
1,403.55
1,227.66
1,229.90
850.24
Total Assets
12,606.19
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
1,802.99
2,005.35
1,392.91
1,798.08
894.15
1,008.84
2,742.12
810.20
599.42
153.48
PBT
1,225.91
1,526.26
1,186.57
561.66
931.01
1,088.09
2,343.44
939.81
843.98
581.60
Adjustment
1,349.95
992.84
876.21
1,418.19
606.92
430.27
552.44
337.96
136.79
126.13
Changes in Working Capital
-351.85
-338.25
-385.83
99.39
-360.16
-125.21
423.58
-409.38
-119.68
-421.75
Cash after chg. in Working capital
2,224.01
2,180.85
1,676.95
2,079.24
1,177.77
1,393.15
3,319.46
868.39
861.09
285.98
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-421.02
-175.50
-284.04
-281.16
-283.62
-384.31
-577.34
-58.19
-261.67
-132.50
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-196.63
-449.42
198.61
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
-241.70
Net Fixed Assets
-29.00
-198.83
-378.80
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
-455.28
Net Investments
-53.72
-179.03
351.33
138.83
310.79
-17.69
-484.32
-111.97
-131.60
287.55
Others
-113.91
-71.56
226.08
230.63
-772.52
-177.21
117.89
216.24
83.80
-73.97
Cash from Financing Activity
-1,781.05
-1,650.79
-1,549.04
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
86.40
19.73
Net Cash Inflow / Outflow
-174.69
-94.86
42.48
242.35
-395.41
29.02
469.12
-139.85
330.01
-68.49
Opening Cash & Equivalents
572.56
661.82
588.76
702.04
1,067.57
1,049.86
612.38
955.05
687.41
760.80
Closing Cash & Equivalent
398.40
572.56
661.82
940.06
702.04
1,067.57
1,049.86
864.95
955.05
687.41

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
175.87
172.45
284.99
279.15
273.11
257.04
206.46
147.16
112.41
84.02
ROA
5.92%
9.20%
7.50%
3.15%
5.81%
10.28%
20.89%
11.71%
15.16%
12.79%
ROE
13.18%
23.49%
21.47%
9.34%
15.12%
23.80%
57.92%
34.19%
39.94%
33.25%
ROCE
14.35%
17.62%
15.28%
9.75%
13.81%
20.36%
45.63%
26.98%
35.06%
31.66%
Fixed Asset Turnover
1.43
1.43
1.48
1.50
1.57
1.35
1.82
1.88
3.11
2.60
Receivable days
37.86
38.92
37.65
33.78
35.74
74.66
82.76
105.19
77.81
68.65
Inventory Days
61.71
59.24
49.84
49.01
57.16
90.90
66.19
81.17
84.02
82.53
Payable days
306.08
383.19
133.47
139.05
150.99
171.27
204.35
176.11
158.58
143.69
Cash Conversion Cycle
-206.50
-285.04
-45.98
-56.26
-58.09
-5.72
-55.41
10.25
3.25
7.50
Total Debt/Equity
0.68
0.83
1.21
1.28
1.40
0.58
0.67
1.10
0.59
0.49
Interest Cover
5.81
5.32
3.63
2.11
4.02
6.29
13.74
6.37
15.40
18.21

News Update:


  • ICRA upgrades Torrent Pharma’s long term credit rating to ‘AA+/Stable’
    26th Aug 2022, 11:19 AM

    ICRA has reaffirmed its rating on commercial paper programme at ‘Al+’

    Read More
  • Torrent Pharma - Quarterly Results
    29th Jul 2022, 18:04 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.